Hjem › Fokal segmental glomerulosklerose › Californien
Fokal segmental glomerulosklerose kliniske forsøg i Californien
8 studier for Fokal segmental glomerulosklerose søger deltagere på steder i Californien.
Byer i Californien
Officiel studietekst (engelsk)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #2, Chula Vista
- Investigator Site #28, Garden Grove
- Investigator Site #14, Los Angeles
- og 1 flere
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07268638A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- West Coast Kidney Institute, Fremont
- Kidney Disease Medical Group, Glendale
- Valiance Clinical Research, Huntington Park
- og 8 flere
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07220083A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- University of California Irvine Medical Center- Site Number : 8400015, Orange
- University of California San Francisco - Parnassus Heights- Site Number : 8400012, San Francisco
RekruttererFase 2
Alder 16 til 75 · Alle køn · Opdateret 23. sep. 2026 · NCT06500702Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
- Loma Linda University Children's Hospital, Loma Linda
- Loma Linda University Hospital, Loma Linda
Rekrutterer
Op til 75 år · Alle køn · Opdateret 28. aug. 2026 · NCT04065438Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- Loma Linda University Children's Hospital, Loma Linda
- Cedars Sinai Medical Center, Los Angeles
Rekrutterer
Op til 21 år · Alle køn · Opdateret 28. aug. 2026 · NCT02235857Nephrotic Syndrome Study Network
- University of Southern California-Children's Hospital, Los Angeles
- Stanford University School of Medicine, Palo Alto
- University of California San Francisco Benioff Children's Hospitals, San Francisco
- og 1 flere
RekruttererObservationsstudie
Op til 80 år · Alle køn · Opdateret 10. jun. 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Cedars-Sinai Medical Center, Los Angeles
RekruttererFase 2
Alder 1 til 17 · Alle køn · Opdateret 12. maj 2026 · NCT05003986A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles, Los Angeles
- Kaiser Permanente, Oakland
- og 2 flere
RekruttererFase 3
Alder 12 til 80 · Alle køn · Opdateret 3. feb. 2026 · NCT05183646Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.